Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Angela Boland
A Systematic Review of Lenvatinib and Sorafenib for Treating Progressive, Locally Advanced or Metastatic, Differentiated Thyroid Cancer After Treatment With Radioactive Iodine
BMC Cancer
Cancer Research
Oncology
Genetics
Related publications
Cost-Effectiveness of Sorafenib for Treatment of Radioactive Iodine (Rai)-Refractory Locally Advanced/Metastatic Differentiated Thyroid Cancer (Dtc) in Turkey
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Estimating the Economic Impact of Sorafenib in Treatment of Locally Recurrent or Metastatic, Progressive, Differentiated Thyroid Carcinoma (DTC) That Is Refractory to Radioactive Iodine (RAI) Treatment
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Dietary Iodine Restriction in Preparation for Radioactive Iodine Treatment or Scanning in Well-Differentiated Thyroid Cancer: A Systematic Review
Thyroid
Medicine
Endocrinology
Metabolism
Diabetes
Budget Impact and Incremental Survival Benefit of Using Lenvatinib as a Treatment for Radioactive Iodine Refractory Differentiated Thyroid Cancer in Russia
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Effectiveness of Chemotherapy in Advanced Differentiated Thyroid Cancer: A Systematic Review
Endocrine-Related Cancer
Cancer Research
Endocrinology
Oncology
Metabolism
Diabetes
Differentiated Thyroid Cancer in Pediatric Population (≤18 Years): Postoperative Treatment With Radioactive Iodine (I-131)
Acta Clinica Croatica
Medicine
Thyroid Storm and Complete Heart Block After Treatment With Radioactive Iodine
Case Reports in Endocrinology
Endocrinology
Metabolism
Diabetes
Interferon-Alfa in the Treatment of Patients With Inoperable Locally Advanced or Metastatic Renal Cell Carcinoma: A Systematic Review
Canadian Urological Association Journal
Urology
Design of RESILIENCE: A Phase 3 Trial Comparing Capecitabine in Combination With Sorafenib or Placebo for Treatment of Locally Advanced or Metastatic HER2-negative Breast Cancer
Breast Cancer Research
Cancer Research
Oncology
